Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's ...

Problematic software has been the cause of multiple infusion pump recalls in the medical device industry over the past few ...

To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment ...

and BD Interventional. Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

and BD Interventional. Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Becton Dickinson (BDX) announced the first patient treated in an investigational device exemption clinical trial intended to advance BD’s ...

BD treated the first subject in the trial with GalaFLEX LITE Scaffold for reducing the recurrence of CC during breast revision surgeries.

The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine Infusion Adapters due to reports that ...

BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.